Related Experiment Video
Updated: Jul 7, 2026
03:40
Intrafemoral Injection of Human Hematopoietic Stem and Progenitor Cells into Immunocompromised Mice
Published on: December 8, 2023
Technology Insight: hematopoietic stem cell transplantation for systemic rheumatic disease
Nikolay P Nikolov1, Steven Z Pavletic
1Sjögren's Syndrome Clinic, Molecular Physiology and Therapeutics Branch of the National Institute of Dental and Craniofacial Research, NIH, Bethesda, MD, USA. nikolovn@mail.nih.gov
Nature Clinical Practice. Rheumatology
|February 21, 2008
Summary
Hematopoietic stem cell (HSC) transplantation shows promise for treating autoimmune diseases by correcting immune system dysregulation. However, its use is limited to clinical research due to the lack of standard conditioning regimens and associated risks.
Area of Science:
- Immunology
- Hematology
- Regenerative Medicine
Background:
- Hematopoietic stem cells (HSCs) possess self-renewal and differentiation capabilities, enabling treatment of various hematologic conditions.
- HSC transplantation is increasingly explored for immune-mediated diseases like multiple sclerosis and rheumatoid arthritis.
- The goal is to reset the immune system, potentially leading to remission or cure of autoimmune disorders.
Purpose of the Study:
- To evaluate the potential of HSC transplantation in treating autoimmune diseases.
- To highlight the challenges and current limitations of this therapeutic approach.
Main Methods:
- Review of current applications and research in HSC transplantation for autoimmune diseases.
- Discussion of the underlying principles of immune system correction via HSCs.
Main Results:
- HSC transplantation has shown potential for sustained remission in immune-mediated diseases.
- Current application is restricted to clinical research settings.
- Standardized conditioning regimens for autoimmune disease treatment are lacking.
Conclusions:
- HSC transplantation offers a potential curative approach for autoimmune diseases by restoring immune homeostasis.
- Patient selection based on risk:benefit ratio is critical due to inherent treatment and disease-related morbidities.
- Further research is needed to establish safe and effective conditioning protocols.
Related Concept Videos
01:22Bone Marrow Sampling and Transplants
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
01:01Regulation of Hematopoietic Stem Cells
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
01:21Stem Cell Therapy for Tissue Regeneration
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
01:19Multipotency of Hematopoietic Stem Cells
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
01:21Hematopoiesis
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
01:22iPS Cell Differentiation
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.